Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scRNA-seq]

ABSTRACT: Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scRNA-seq]

PROVIDER: PRJNA1041323 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26852321_1.fastq.gz	Fastqsanger.gz
	SRR26852321_2.fastq.gz	Fastqsanger.gz
	SRR26852322_1.fastq.gz	Fastqsanger.gz
	SRR26852322_2.fastq.gz	Fastqsanger.gz
	SRR26852323_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation

Project description:Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation

| PRJNA1041319 | ENA

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scATAC-seq]

Project description:Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scATAC-seq]

| PRJNA944632 | ENA

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [bulk ATAC-seq]

Project description:Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [bulk ATAC-seq]

| PRJNA1041324 | ENA

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scRNA-seq]

Project description:Hematopoietic stem cell mutations can result in clonal hematopoiesis (CHIP) but the clinical outcomes are heterogeneous. The nature of the founder mutation and secondary mutations likely drive emergent neoplastic disease. We investigated how the cell state where the TET2 mutation occurs affects susceptibility to that commonly occurring CH mutation. Here, we provide evidence that risk is written in the epigenome of the cell of origin. By characterizing cell states that underlie myeloid differentiation and linking this information to an inducible system to assess myeloid progenitor clones, we provide evidence that epigenetic markers of the cell where Tet2 mutation occurs stratifies clonal behaviors. Specifically, Sox4 fosters a global cell state of high sensitization towards Tet2 KO. Using GMP and primary HSC models, we show that Sox4 promotes cell dedifferentiation, alters cell metabolism and increases the in vivo clonal output of mutant cells. Our results validate the hypothesis that epigenetic features can predispose specific clones for dominance and explain why an identical mutation can result in different outcomes.

2024-03-14 | GSE247968 | GEO

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [scATAC-seq]

2024-03-14 | GSE227314 | GEO

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation [bulk ATAC-seq]

2024-03-14 | GSE247969 | GEO

Cell of origin epigenetic priming determines susceptibility to Tet2 mutation

Project description:Hematopoietic stem cell (HSC) mutations can result in clonal hematopoiesis (CH) with heterogeneous clinical outcomes. Here, we investigated how the cell state preceding Tet2 mutation impacts the pre-malignant phenotype. Using an inducible system for clonal analysis of myeloid progenitors, we found that the epigenetic features of clones at similar differentiation status were highly heterogeneous and functionally responded differently to Tet2 mutation. Cell differentiation stage also influenced Tet2 mutation response indicating that the cell of origin's epigenome modulates clone-specific behaviors in CH. Molecular features associated with higher risk outcomes include Sox4 that sensitized cells to Tet2 inactivation, inducing dedifferentiation, altered metabolism and increasing the in vivo clonal output of mutant cells, as confirmed in primary GMP and HSC models. Our findings validate the hypothesis that epigenetic features can predispose specific clones for dominance, explaining why identical genetic mutations can result in different phenotypes.

1970-01-01 | MTBLS9914 | MetaboLights

Cell of origin epigenetic priming determines susceptibility to Tet2 oncogenic mutation

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-03-14 | GSE247970 | GEO

Developmental priming of cancer susceptibility

Project description:Developmental priming of cancer susceptibility

| PRJNA1093044 | ENA

Gender determines susceptibility to methamphetamine cardiomyopathy in mice

Project description:Gender determines susceptibility to methamphetamine cardiomyopathy in mice

| PRJNA432048 | ENA